Alnylam Pharmaceuticals
(ALNY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,591 | -7,889 | -26,249 | -16,857 | -13,999 |
| Depreciation Amortization | 3,745 | 1,802 | 5,726 | 3,928 | 2,297 |
| Income taxes - deferred | -250 | -237 | -5,501 | 16 | 32 |
| Accounts receivable | -1,669 | -1,643 | 843 | -19,109 | -95 |
| Accounts payable and accrued liabilities | 3,875 | 6,141 | -1,238 | -484 | 2,414 |
| Other Working Capital | -20,676 | 824 | 63,900 | 62,967 | 86,225 |
| Other Operating Activity | 10,878 | 2,233 | 28,010 | 39,879 | 9,476 |
| Operating Cash Flow | $-34,688 | $1,231 | $65,491 | $70,340 | $86,350 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -4,436 | 43,011 | 28,800 | 24,117 | 58,186 |
| PPE Investments | -2,947 | -1,885 | -10,764 | -9,480 | -7,198 |
| Purchase Of Investment | -10,000 | -10,000 | -100 | -100 | N/A |
| Other Investing Activity | 6,151 | 2,999 | 0 | 0 | 0 |
| Investing Cash Flow | $-11,232 | $34,125 | $17,936 | $14,537 | $50,988 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -6,758 | -2,812 | -1,852 |
| Common Stock Issued | 2,111 | N/A | 9,913 | 9,451 | 6,884 |
| Other Financing Activity | 0 | 210 | 0 | 0 | 0 |
| Financing Cash Flow | $2,111 | $210 | $3,155 | $6,639 | $5,032 |
| Exchange Rate Effect | -113 | -90 | 53 | 64 | 9 |
| Beginning Cash Position | 191,792 | 191,792 | 105,157 | 105,157 | 105,157 |
| End Cash Position | 147,870 | 227,268 | 191,792 | 196,737 | 247,536 |
| Net Cash Flow | $-43,922 | $35,476 | $86,635 | $91,580 | $142,379 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,688 | 1,231 | 65,491 | 70,340 | 86,350 |
| Capital Expenditure | -2,947 | -1,885 | -10,764 | -9,480 | -7,198 |
| Free Cash Flow | -37,635 | -654 | 54,727 | 60,860 | 79,152 |